The diagnosis and treatment of limbic encephalitis

Acta Neurologica Scandinavica

Volumn 126, Issue 6, 2012, Pages 365-375

  Asztely, F ^a   Kumlien, E ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autoimmune limbic encephalitis; Limbic encephalitis; Limbic system; Paraneoplastic limbic encephalitis; Paraneoplastic syndromes

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AMPA RECEPTOR; CYCLOPHOSPHAMIDE; GLUTAMATE DECARBOXYLASE; GLYCINE RECEPTOR; IMMUNOGLOBULIN; MEMBRANE ANTIGEN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREDNISOLONE; RITUXIMAB; VOLTAGE GATED POTASSIUM CHANNEL;

AMNESIA; CONFUSION; ELECTROENCEPHALOGRAM; HUMAN; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; SEIZURE; SHORT TERM MEMORY;

HUMANS; LIMBIC ENCEPHALITIS;

EID: 84868193661     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2012.01691.x     Document Type: Review

References (116)

1. Brierley JB, Corsellis JA, Hierons R, Nevin S Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 1960;83:357-68.
2. Corsellis JA, Goldberg GJ, Norton AR "Limbic encephalitis" and its association with carcinoma. Brain 1968;91:481-96.
3. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988;38:1391-8.
4. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991;41:1757-64.
5. Graus F, Cordon-Cardo C, Posner JB Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985;35:538-43.
6. Bakheit AM, Kennedy PG, Behan PO Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry 1990;53:1084-8.
7. Graus F, Delattre JY, Antoine JC et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40.
8. Dalmau J, Rosenfeld MR Paraneoplastic syndromes of the CNS. Lancet Neurol 2008;7:327-40.
9. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;7:1481-94.
10. Voltz R Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 2002;1:294-305.
11. Albert ML, Austin LM, Darnell RB Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 2000;47:9-17.
12. Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999;45:162-7.
13. Rousseau A, Benyahia B, Dalmau J et al. T cell response to Hu-D peptides in patients with anti-Hu syndrome. J Neurooncol 2005;71:231-6.
14. Bien CG, Schulze-Bonhage A, Deckert M et al. Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy. Neurology 2000;55:1823-8.
15. Ances BM, Vitaliani R, Taylor RA et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005;128:1764-77.
16. Mori M, Kuwabara S, Yoshiyama M, Kanesaka T, Ogata T, Hattori T Successful immune treatment for non-paraneoplastic limbic encephalitis. J Neurol Sci 2002;201:85-8.
17. Honnorat J, Antoine JC Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2007;2:22.
18. Schott JM Limbic encephalitis: a clinician's guide. Practical Neurology 2006;6:143-53.
19. Buckley C, Oger J, Clover L et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-8.
20. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177-82.
21. Graus F, Saiz A, Dalmau J Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257:509-17.
22. Graus F, Saiz A, Lai M et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 2008;71:930-6.
23. Vincent A, Buckley C, Schott JM et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12.
24. Sansing LH, Tuzun E, Ko MW, Baccon J, Lynch DR, Dalmau J A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007;3:291-6.
25. Dalmau J, Tuzun E, Wu HY et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
26. Lancaster E, Lai M, Peng X et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76.
27. Vedeler CA, Storstein A Autoimmune limbic encephalitis. Acta Neurol Scand 2009;120(Suppl. 189):63-7.
28. Lai M, Hughes EG, Peng X et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-34.
29. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 2010;81:1167-9.
30. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67:470-8.
31. Pozo-Rosich P, Clover L, Saiz A, Vincent A, Graus F Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 2003;54:530-3.
32. Lancaster E, Martinez-Hernandez E, Dalmau J Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011;77:179-89.
33. Bien CG, Scheffer IE Autoantibodies and epilepsy. Epilepsia 2011;52(Suppl 3):18-22.
34. Irani SR, Bien CG, Lang B Autoimmune epilepsies. Curr Opin Neurol 2011;24:146-53.
35. Hughes EG, Peng X, Gleichman AJ et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866-75.
36. Lai M, Huijbers MG, Lancaster E et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-85.
37. Moscato EH, Jain A, Peng X, Hughes EG, Dalmau J, Balice-Gordon RJ Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci 2010;32:298-309.
38. Irani SR, Michell AW, Lang B et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:892-900.
39. Dalmau J, Gleichman AJ, Hughes EG et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-8.
40. Saiz A, Blanco Y, Sabater L et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553-63.
41. Vincent A Stiff, twitchy or wobbly: are GAD antibodies pathogenic? Brain 2008;131:2536-7.
42. Ahmad SA, Archer HA, Rice CM, Gerhand S, Bradley M, Wilkins A Seronegative limbic encephalitis: case report, literature review and proposed treatment algorithm. Pract Neurol 2011;11:355-61.
43. Kondziella D, Andersen O, Asztely F, Holmberg B, Hedstrom A, Szentgyorgyi E Excellent outcome after prolonged status epilepticus due to non-paraneoplastic limbic encephalitis. Acta Neurol Belg 2008;108:21-3.
44. Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 2007;78:381-5.
45. Samarasekera SR, Vincent A, Welch JL, Jackson M, Nichols P, Griffiths TD Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry 2007;78:391-4.
46. Alamowitch S, Graus F, Uchuya M, Rene R, Bescansa E, Delattre JY Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 1997;6:923-8.
47. Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 2003;78:1363-8.
48. Kayser MS, Kohler CG, Dalmau J Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry 2010;167:1039-50.
49. Scheid R, Lincke T, Voltz R, Von CRAMON DY, Sabri O Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol 2004;61:1785-9.
50. Basu S, Alavi A Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol 2008;10:131-7.
51. Granerod J, Ambrose HE, Davies NW et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010;10:835-44.
52. Glaser CA, Gilliam S, Honarmand S et al. Refractory status epilepticus in suspect encephalitis. Neurocrit Care 2008;9:74-82.
53. Mailles A, Stahl JP Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009;49:1838-47.
54. Scheid R, Voltz R, Vetter T, Sabri O, Von CRAMON DY Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses. J Neurol 2005;252:1129-32.
55. Seeley WW, Marty FM, Holmes TM et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007;69:156-65.
56. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001;56:1313-8.
57. Sonneville R, Demeret S, Klein I et al. Acute disseminated encephalomyelitisin the intensive care unit:clinical features and outcome of 20 adults. Intensive Care Med 2008;34:528-32.
58. De SEZE J, Debouverie M, Zephir H et al. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol 2007;64:1426-32.
59. Murray K Creutzfeldt-Jacob disease mimics, or how to sort out the subacute encephalopathy patient. Practical Neurology 2010;11:19-28.
60. Geschwind MD, Tan KM, Lennon VA et al. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol 2008;65:1341-6.
61. Saiz A, Graus F, Dalmau J, Pifarre A, Marin C, Tolosa E Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 1999;46:774-7.
62. Galvin R, Brathen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol 2010;17:1408-18.
63. Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 2008;19:178-84.
64. Kaplan PW, Birbeck G Lithium-induced confusional states: nonconvulsive status epilepticus or triphasic encephalopathy? Epilepsia 2006;47:2071-4.
65. Kunze K Metabolic encephalopathies. J Neurol 2002;249:1150-9.
66. Mckeon A, Frye MA, Delanty N The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry 2008;79:854-62.
67. Smith SJ, Kocen RS A Creutzfeldt-Jakob like syndrome due to lithium toxicity. J Neurol Neurosurg Psychiatry 1988;51:120-3.
68. Kano O, Arasaki K, Ikeda K et al. Limbic encephalitis associated with systemic lupus erythematosus. Lupus 2009;18:1316-9.
69. Kumar N, Leep HUNDERFUND AN, Kutzbach BR, Pulido JS, Miller GM A limbic encephalitis MR imaging in a patient with Behcet disease and relapsing polychondritis. AJNR Am J Neuroradiol 2009;30:E96.
70. Ohta Y, Nagano I, Niiya D et al. Nonparaneoplastic limbic encephalitis with relapsing polychondritis. J Neurol Sci 2004;220:85-8.
71. Stubgen JP Nervous system lupus mimics limbic encephalitis. Lupus 1998;7:557-60.
72. Delalande S, De SEZE J, Fauchais AL et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 2004;83:280-91.
73. Birnbaum J, Hellmann DB Primary angiitis of the central nervous system. Arch Neurol 2009;66:704-9.
74. Joseph FG, Scolding NJ Cerebral vasculitis a practical approach. Practical Neurology 2002;2:80-93.
75. Molloy ES, Hajj-Ali RA Primary angiitis of the central nervous system. Curr Treat Options Neurol 2007;9:169-75.
76. Bataille B, Delwail V, Menet E et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92:261-6.
77. Rees JH, Howard RS High-grade glioma mimicking acute viral encephalitis-three case reports. Postgrad Med J 1999;75:727-30.
78. Sierra DEL RIO M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K Primary CNS lymphoma in immunocompetent patients. Oncologist 2009;14:526-39.
79. Whitley RJ, Cobbs CG, Alford CA, Jr et al. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA 1989;262:234-9.
80. Brain L, Jellinek EH, Ball K Hashimoto's disease and encephalopathy. Lancet 1966;2:512-4.
81. Tuzun E, Erdag E, Durmus H et al. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis. Neurol India 2011;59:47-50.
82. Nakamura H, Usa T, Motomura M et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest 2008;31:861-5.
83. Schiess N, Pardo CA Hashimoto's encephalopathy. Ann N Y Acad Sci 2008;1142:254-65.
84. Chong JY, Rowland LP, Utiger RD Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003;60:164-71.
85. Tuzun E, Dalmau J Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007;13:261-71.
86. Keime-Guibert F, Graus F, Broet P et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999;53:1719-23.
87. Seki M, Suzuki S, Iizuka T et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008;79:324-6.
88. Rosenfeld MR, Dalmau J Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol 2011;13:324-32.
89. Titulaer MJ, Soffietti R, Dalmau J et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011;18:19-27.
90. Pittock SJ, Kryzer TJ, Lennon VA Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004;56:715-9.
91. Younes-Mhenni S, Janier MF, Cinotti L et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 2004;127:2331-8.
92. Mckeon A, Apiwattanakul M, Lachance DH et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol 2010;67:322-9.
93. Bien CG, Elger CE Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 2007;10:529-38.
94. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
95. Pelosof LC, Gerber DE Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010;85:838-54.
96. Grisold W, Giometto B, Vitaliani R, Oberndorfer S Current approaches to the treatment of paraneoplastic encephalitis. Ther Adv Neurol Disord 2011;4:237-48.
97. Ishiura H, Matsuda S, Higashihara M et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 2008;71:1921-3.
98. Frechette ES, Zhou L, Galetta SL, Chen L, Dalmau J Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis. Neurology 2011;76:S64-6.
99. Honnorat J, Cartalat-Carel S, Ricard D et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2009;80:412-6.
100. Roberts WK, Darnell RB Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 2004;16:616-22.
101. Tani T, Tanaka K, Idezuka J, Nishizawa M Regulatory T cells in paraneoplastic neurological syndromes. J Neuroimmunol 2008;196:166-9.
102. Bernal F, Graus F, Pifarre A, Saiz A, Benyahia B, Ribalta T Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol 2002;103:509-15.
103. Jean WC, Dalmau J, Ho A, Posner JB Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 1994;44:140-7.
104. Roberts WK, Deluca IJ, Thomas A et al. Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. J Clin Invest 2009;119:2042-51.
105. Vedeler CA, Antoine JC, Giometto B et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 2006;13:682-90.
106. Dalmau J, Graus F, Villarejo A et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004;127:1831-44.
107. Vernino S, O'neill BP, Marks RS, O'fallon JR, Kimmel DW Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol 2004;6:55-62.
108. Shams'ili S, De BEUKELAAR J, Gratama JW et al. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 2006;253:16-20.
109. Irani SR, Bera K, Waters P et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2009;133:1655-67.
110. Alper K, Schwartz KA, Kolts RL, Khan A Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007;62:345-54.
111. Henning OJ, Nakken KO Psychiatric comorbidity and use of psychotropic drugs in epilepsy patients. Acta Neurol Scand 2010;122(Suppl. 190):18-22.
112. Kanner AM The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol 2008;28:379-88.
113. Patsalos PN, Perucca E Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003;2:473-81.
114. Van SWIETEN JC, Koudstaal PJ, Visser MC, Schouten HJ, Van GIJN J Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
115. Graus F, Keime-Guibert F, Rene R et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124:1138-48.
116. Folstein MF, Folstein SE, Mchugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.